Funds and ETFs McKesson Corporation

Equities

MCK

US58155Q1031

Pharmaceuticals

Real-time Estimate Cboe BZX 12:30:08 2024-05-17 pm EDT 5-day change 1st Jan Change
561.2 USD +0.98% Intraday chart for McKesson Corporation +0.18% +21.16%

ETFs positioned on McKesson Corporation

Name Weight AuM 1st Jan change Investor Rating
2.43% 9 M€ 0.00%
2.31% 1,085 M€ +8.46% -
1.18% 204 M€ +10.54%
1.08% 17 M€ +7.73% -
0.67% 3 M€ +15.16% -
0.67% 4 M€ -.--% -
0.67% 13 M€ -.--% -
0.61% 9 M€ +10.60%
0.60% 9 M€ -.--% -
0.58% 5 M€ -.--% -
0.50% 5 M€ -72.95% -
0.35% 1,174 M€ +23.54%
0.35% 273 M€ -.--%
0.35% 655 M€ -.--% -
0.34% 375 M€ +9.24%
0.32% 205 M€ -.--%
0.29% 26 M€ +16.85% -
0.23% 85 M€ +13.83% -
0.21% 1 M€ +0.04%
0.20% 26 M€ +21.55% -
0.18% 8 M€ +7.51% -
0.18% 744 M€ +9.63%
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (87%); - distribution of medical and surgical products (4%); - other (1.6%): primarily technology services and software sales. The remaining net sales (7.4%) are from international activities.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
555.8 USD
Average target price
579.9 USD
Spread / Average Target
+4.34%
Consensus
  1. Stock Market
  2. Equities
  3. MCK Stock
  4. Funds and ETFs McKesson Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW